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Abstracts

PROFESSIONAL SYMPOSIA ABSTRACTS
Abstracts are listed alphabetically by the last name of the first author listed.
DOES DEFICIENCY IN T-CELL SIGNALING
PROTEIN, JAK3, AFFECT THE DEVELOPMENT
OF MURINE TYPE 1 DIABETES?
Cordelia Dunai and Marina Cetkovic-Cvrlje (Advisor)
Department of Biological Sciences
St. Cloud State University, St. Cloud, MN
Janus tyrosine kinase (JAK)3-deficient mice lack
a JAK3 protein essential for an intracellular signaling
pathway that alters the proliferative capacity of T-cells.
As T-cells play a crucial role in pathogenesis of
autoimmune type 1 diabetes (T1D), we hypothesized that
JAK3 deficiency would protect mice against the
development of diabetes.
T1D was induced in JAK3-deficient and wild
type (wt) male C57BL/6J mice by multiple low-dose (40
mg/kg) streptozotocin (STZ) injections. While all of the
control STZ-treated wt mice became diabetic by day 21,
36% of JAK3-deficient mice remained diabetes-free. The
immune responses of JAK3-deficient and wt mice
exposed to STZ were characterized and compared by
measuring T-cell proliferation, T-cell immunophenotypes,
and production of cytokines (IL-2, IL-4, IL-10, IFNgamma, TNF, IL-6, IL-17). JAK3-deficient T-cells were
found to be unable to proliferate in vitro in response to
stimulation by concanavalin A. The percentages of CD3and CD4-positive T-cells were increased, and CD8positive decreased in JAK3-deficient compared with wt
mice. JAK3-deficient mice expressed only negligible
levels of CD4-/CD25-/Foxp3-positive T-cells, while an
anergic regulatory CD4/PD-1-positive T-cell population
was increased. STZ treatment reduced the populations of
CD3-, CD4-, and CD8-positive T-cells. The cytokine
profiles of JAK3-deficient mice revealed lower levels of
all cytokines measured, except the regulatory IL-10,
which was significantly higher.
In conclusion, the combination of these immune
response parameters seems to be responsible for the
reduced diabetes incidence in STZ- treated JAK3deficient mice. These results provide an additional
evidence for a strategy for preventing the development of
T1D by inhibiting JAK3.

EFFECT OF MULTIPLE LOW DOSES AND
SINGLE HIGH DOSE OF STREPTOZOTOCIN
ON T-REGLUATORY AND TH17 CELLS IN
C57BLJ/6 MOUSE SPLENOCYTES
Joe Hobbs and Marina Cetkovic-Cvrlje (Advisor)
Department of Biological Sciences
Saint Cloud State University, Saint Cloud, MN
Type 1 diabetes (T1D) is an autoimmune
disease that is characterized by destruction of the
insulin-producing β-cells in pancreatic islets. Two
experimental models for studying T1D use a selective
pancreatic β-cell toxin called streptozotocin (STZ) for
disease induction. If STZ is administered in five
consecutive low doses (LDSTZ), a T-cell-mediated
destruction of β-cells is observed. Conversely, a single
high dose of STZ (HDSTZ) causes a toxic destruction
of β-cells.
The goal of this study was to characterize
immune responses in LDSTZ- and HDSTZ-treated
C57BL/6J male mice throughout the course of disease
development by investigating T-cell proliferation
(Concanavalin A stimulation), cytokine production
(flow cytometry), and the percentages of T-cell
subpopulations (flow cytometry). It is found that
LDSTZ-induced T1D is a T-cell-dependent process,
characterized by a decrease in splenic CD3+, CD4+,
CD8+, and CD4+CD62L+ cell populations, along with
a decrease in their pro-inflammatory cytokines, such as
IFN-γ, TNF-α, and IL-17; and an increase in regulatory
T-cell population (CD4+CD25+Foxp3+) and its antiinflammatory cytokine IL-10. These data suggest that
protective anti-inflammatory response develops in the
spleen of LDSTZ-treated mice in order to compensate
for an ongoing pathogenic pro-inflammatory immune
response in the pancreas. In contrast, HDSTZ-treated
mice did exhibit neither a reduction in T-cell
subpopulations, nor significant changes in cytokine
secretion, confirming a non-immune nature of the βcells destruction.
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THE IMPACTS OF GREEN CHEMISTRY ON THE
SCIENTIFIC ENTERPRISE: STORIES OF
INSPIRATION, INNOVATION, AND RESOURCE
USE
Paul Jackson, Associate Professor
Chemistry Department & Environmental Studies
Department
St. Olaf College, Northfield, MN
Over the last decade green chemistry has gained
a foothold in industry practice, chemical design and
chemical education. At its foundation green chemistry
seeks to minimize the impact of chemical processes and
products on the environment. Just how does green
chemistry contribute to and transform the scientific
enterprise? This presentation will explore the impacts
green chemistry makes; we will highlight the 12 guiding
principles of green chemistry and its historic context,
share examples of innovation in green chemistry across
commercial and educational sectors, and discuss how this
practice reframes resource use. Using the recently
constructed, USGBC LEED Platinum rated, Regents Hall
of Natural Science at St. Olaf College as a case study, we
will explore the impacts green chemistry makes on
science facility design and operation as well as the
learning community housed within its walls. The
implications of these lessons go well beyond the
undergraduate classroom and speak to science education
infrastructure supporting education at earlier learning
levels. We will finish with a summary of efforts to use
green chemistry as an economic redevelopment tool and
the recent activity of the Minnesota Green Chemistry
Forum.
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AN EMBRYONIC ISOFORM OF P53 CONTROLS
THE EPIGENETIC MODIFIER MYST2 IN ESCS
Robbyn Weaver, Olga Sarmento, Rosanna Beraldi, and
Heidi Scrable (Advisor)
Department of Biochemistry and Molecular Biology
Mayo Graduate School, Rochester, MN
The transcription factor p53 is a tumor
suppressor that has several isoforms generated from
alternate splicing and alternative promoter usage. The
embryonic isoform, ∆40p53, can bind full length p53 and
may therefore modify and alter p53 activities.
Histone acetylation is associated with activation
of transcription of genes. The activity of the histone
acetyltransferase Myst2 is necessary for global acetylation
of histone 4 and also for proper docking of the prerecognition complex cellular replication licensing.
Furthermore, Myst2 can be repressed by full length p53
through direct protein-protein interactions.
These
findings demonstrate that p53 may control cell replication
and gene expression through an epigenetic mechanism.
We have isolated embryonic stem cells from
transgenic mice expressing an extra copy of ∆40p53
(∆40p53Tg) which have an accelerated aging phenotype,
and we have engineered embryonic stem cells with only a
single copy of ∆40p53 (∆p44). We have found several
dose-dependent effects of ∆40p53 on cellular morphology
and protein expression of these cell populations. One
characteristic of ∆p44 ESCs is abnormal nuclei, and we
hypothesize that insufficient levels of ∆40p53 interfere
with proper replication licensing by Myst2. Additionally,
∆p44 ESCs appear to differentiate spontaneously, perhaps
due to decreased expression of pluripotency genes such as
Oct4 which rely on H4 acetylation to remain
transcriptionally activated. Therefore, the dose of ∆40p53
appears to modify Myst2 expression, leading to changes
in gene expression and replication, and we hypothesize
that these epigenetic modifications made during early
development will contribute to a later life phenotype.

